227 related articles for article (PubMed ID: 23567304)
41. Systemic and airway inflammation and the presence of emphysema in patients with COPD.
Papaioannou AI; Mazioti A; Kiropoulos T; Tsilioni I; Koutsokera A; Tanou K; Nikoulis DJ; Georgoulias P; Zakynthinos E; Gourgoulianis KI; Kostikas K
Respir Med; 2010 Feb; 104(2):275-82. PubMed ID: 19854037
[TBL] [Abstract][Full Text] [Related]
42. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease.
Chan KH; Yeung SC; Yao TJ; Ip MS; Cheung AH; Chan-Yeung MM; Mak JC;
Int J Tuberc Lung Dis; 2010 Sep; 14(9):1193-200. PubMed ID: 20819268
[TBL] [Abstract][Full Text] [Related]
43. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
44. Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ann Nutr Metab; 2011; 58(3):197-202. PubMed ID: 21757893
[TBL] [Abstract][Full Text] [Related]
45. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
46. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training.
Byrkjeland R; Nilsson BB; Westheim AS; Arnesen H; Seljeflot I
Scand J Clin Lab Invest; 2011 Nov; 71(7):598-605. PubMed ID: 21831004
[TBL] [Abstract][Full Text] [Related]
48. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
Caram LMO; Ferrari R; Nogueira DL; Oliveira M; Francisqueti FV; Tanni SE; Corrêa CR; Godoy I
Int J Chron Obstruct Pulmon Dis; 2017; 12():2015-2021. PubMed ID: 28744116
[TBL] [Abstract][Full Text] [Related]
49. The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms?
Marushchak M; Maksiv K; Krynytska I; Dutchak O; Behosh N
J Med Life; 2019; 12(4):426-434. PubMed ID: 32025262
[TBL] [Abstract][Full Text] [Related]
50. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers.
Hacievliyagil SS; Mutlu LC; Temel İ
Niger J Clin Pract; 2013; 16(1):76-81. PubMed ID: 23377476
[TBL] [Abstract][Full Text] [Related]
51. Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease.
Rubinsztajn R; Przybyłowski T; Maskey-Warzęchowska M; Paplińska-Goryca M; Karwat K; Nejman-Gryz P; Chazan R
Pneumonol Alergol Pol; 2015; 83(2):120-5. PubMed ID: 25754053
[TBL] [Abstract][Full Text] [Related]
52. Markers of systemic involvement in chronic obstructive pulmonary disease.
Albu A; Fodor D; Poantă L; Man M
Rom J Intern Med; 2012; 50(2):129-34. PubMed ID: 23326956
[TBL] [Abstract][Full Text] [Related]
53. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
[TBL] [Abstract][Full Text] [Related]
54. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
55. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
[TBL] [Abstract][Full Text] [Related]
56. The traditional herbal medicine Hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease.
Shinozuka N; Tatsumi K; Nakamura A; Terada J; Kuriyama T
J Am Geriatr Soc; 2007 Feb; 55(2):313-4. PubMed ID: 17302677
[No Abstract] [Full Text] [Related]
57. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
[TBL] [Abstract][Full Text] [Related]
58. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
Thomsen M; Dahl M; Lange P; Vestbo J; Nordestgaard BG
Am J Respir Crit Care Med; 2012 Nov; 186(10):982-8. PubMed ID: 22983959
[TBL] [Abstract][Full Text] [Related]
59. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
60. [The effect of glucocorticoid on IL-8 expressing in lung tissue of rat with chronic obstructive pulmonary disease].
Zhang Y; Yang SR; Cheng DY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):287-90. PubMed ID: 17441351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
